If you’re comparing testosterone cream vs injections for men over 50, the real question isn’t which option sounds easier. It’s which delivery method gives you the most predictable levels, the lowest friction, and the cleanest safety profile for your actual life.

That matters because TRT can look deceptively simple from the outside. A telehealth clinic makes it sound like a lifestyle upgrade. A forum makes it sound like everyone just needs more milligrams and a smaller needle. Reality is less glamorous. Delivery method changes absorption, day-to-day stability, DHT conversion, hematocrit risk, lab timing, and how much room there is for protocol mistakes.

The straight take: cream usually gives steadier daily levels and lower erythrocytosis risk, while injections deliver a more predictable dose into circulation and cost less. For men over 50, the smartest choice is often less about ideology and more about whether you value smoother physiology or simpler dose certainty, then building the protocol carefully with your provider.

How Topical and Injectable Testosterone Enter the Body Differently

Cream and injections solve the same problem in completely different ways.

An injection bypasses the skin and puts testosterone directly into muscle tissue, where it is absorbed into circulation with near-complete bioavailability. That makes the delivered dose more predictable. If the prescription says 60 mg or 100 mg, you can be fairly confident most of that dose is getting where it’s supposed to go.

Topical testosterone is messier. According to AlphaMD, standard transdermal delivery gets only about 9% to 14% of the applied dose into systemic circulation because skin is built to keep things out, not wave them through like a hotel concierge. That doesn’t make cream ineffective. It means absorption depends on formulation, skin thickness, application site, and the individual man using it.

Application site matters more than most men realize. In an Andrology study by Iyer and colleagues, scrotal application of compounded testosterone cream produced roughly eightfold higher absorption than abdominal application. A 12.5 mg scrotal dose reached a similar maximum serum concentration to 100 mg applied on the abdomen. That’s not a small tweak. That’s the difference between a product that barely moves the needle and one that changes labs fast.

This is why “cream vs injections” isn’t just a convenience question. Injections deliver the hormone more directly. Cream requires better protocol discipline. If the product, dose, or site is wrong, the apparent failure may be absorption mechanics rather than testosterone itself.

Serum Stability: Why the Peak-and-Trough Pattern Matters

This is where cream often pulls ahead.

One of the better arguments for transdermal therapy is that it tends to create smaller swings across the week. In a prospective study cited in the American Journal of Physiology, daily testosterone gel produced a mean peak-to-trough fluctuation in free testosterone of 2.7 pg/mL. Biweekly intramuscular injections came in at 26.7 pg/mL. That’s a different experience, not just a different number.

Those swings matter because symptoms often follow the curve. A large injection can produce supraphysiological levels within the first 24 to 48 hours, sometimes above 1,100 ng/dL after a 200 mg dose, then decline steadily toward the next trough, as the Endocrine Society guideline notes. Some men feel that as a burst of energy followed by a slide. Others mostly notice it in mood, libido, sleep, or estradiol-related side effects.

Cream, by contrast, behaves more like a daily-input system. Apply it, absorb it, repeat tomorrow. That doesn’t perfectly mimic native production, but it usually creates a smoother pattern than a once-weekly or every-two-weeks injection schedule.

The catch is that injection stability is also a protocol-design problem, not a fixed law of nature. A man using 50 to 60 mg twice weekly will usually see a flatter curve than a man using 200 mg every two weeks. So the right comparison isn’t “cream versus all injections.” It’s cream versus the specific injection schedule being proposed.

For a man over 50 who already notices sleep disruption, blood pressure drift, or mood volatility, those peaks and troughs aren’t trivial. Stable levels can be the difference between TRT feeling boring and TRT feeling like a small endocrine rollercoaster.

Erythrocytosis Risk: The Most Clinically Significant Side Effect Difference

If there is one practical reason many clinicians lean cautious with injections in older men, this is it.

In a 2015 Sexual Medicine study, Pastuszak and colleagues found erythrocytosis, defined as hematocrit above 50%, in 66.7% of men using injectable testosterone compared with 12.8% of men using testosterone gels. Injectable therapy also drove earlier onset of elevated hematocrit, at an average of 10.5 months versus 14.0 months with gels.

That gap is hard to wave away. Elevated hematocrit thickens the clinical conversation quickly because it pushes monitoring, dose adjustment, and sometimes blood donation or therapeutic phlebotomy into the picture. For men over 50, that matters more because baseline cardiovascular risk is already higher than it was at 35, even before TRT enters the equation.

The 2023 TRAVERSE trial in the New England Journal of Medicine found testosterone therapy was noninferior to placebo for major adverse cardiovascular events, which was a meaningful and overdue correction to a lot of hand-wavy fear. But TRAVERSE also reported higher rates of pulmonary embolism and atrial fibrillation in the testosterone group. That doesn’t mean TRT is unsafe across the board. It means hematocrit management isn’t optional theater.

This is where route selection becomes a risk-management decision. If a patient already runs high-normal hematocrit, has sleep apnea that isn’t well controlled, or has shown a strong erythrocytosis response before, the smoother profile of topical therapy can be attractive. Not because cream is magic, but because the side-effect math may be better.

Testosterone Cream vs Injections Men Over 50: DHT Conversion and the Scrotal Cream Advantage

If injections tend to win on delivery certainty, cream has a different edge: local enzyme activity in the skin.

Transdermal testosterone produces a higher dihydrotestosterone to testosterone ratio than injections because skin contains 5-alpha-reductase, the enzyme that converts testosterone to DHT. That effect becomes much more pronounced with scrotal application, where 5-alpha-reductase density is substantially higher than on the arm or abdomen.

In the Iyer Andrology paper, a 25 mg compounded scrotal cream dose produced therapeutic serum testosterone levels within about two hours and maintained physiologic levels for up to 16 hours. Serum DHT peaked at roughly 4.9 hours after application. In plain English: scrotal cream can work fast, absorb extremely well, and push DHT harder than many injection protocols.

For some men, that is part of the appeal. Higher DHT can correlate with better libido, stronger sense of well-being, and more pronounced androgenic effect. For others, it raises obvious questions around hair loss, scalp sensitivity, acne, or prostate symptoms. This isn’t a universal good or bad. It’s a tradeoff.

The other important detail is regulatory, not just physiological. The FDA-approved gels explicitly prohibit scrotal use. When clinics discuss scrotal application, they are generally talking about compounded cream and an off-label protocol. That doesn’t make it reckless, but it does mean the prescribing clinician should be comfortable with the pharmacology and the follow-up plan.

This is also a good example of why broad TRT advice on the internet is often junk. “Use cream” is incomplete. “Use cream scrotally” is still incomplete. The relevant question is which formulation, at what dose, on what site, with what DHT tolerance, and with what follow-up labs.

Protocol Design for Men Over 50: Age-Relevant Factors

By this point the theme should be obvious: protocol design matters at least as much as route.

The TRAVERSE trial enrolled 5,204 men ages 45 to 80 and found TRT noninferior to placebo for major adverse cardiovascular events, with a hazard ratio of 0.96. That result helped drive the FDA’s February 28, 2025 labeling changes removing the old black-box cardiovascular warning. Good. That warning had become a kind of bureaucratic ghost story.

But “TRT isn’t broadly cardiotoxic” doesn’t mean “every protocol is equally smart for a 58-year-old man.” Age changes the terrain. Sex hormone-binding globulin tends to rise around 1% per year after age 40, which can leave total testosterone looking respectable while free testosterone tells a less cheerful story. Men over 50 also tend to bring more baggage into the decision: sleep apnea risk, blood pressure medication, mild prostate enlargement, or a CBC that is already edging upward.

That’s why many clinicians start injectable dosing lower in this age group, often around 50 to 75 mg weekly rather than jumping straight to the old 100 to 200 mg playbook. Split dosing can help further. The Endocrine Society guideline supports adjusting dose and frequency to reduce the peak-and-trough problem, which is exactly the sort of boring optimization that prevents avoidable problems later.

Cream has its own design demands. Daily adherence matters. Lab timing matters. Transfer risk matters, especially if a partner, child, or grandchild could have secondary skin contact. FDA labeling on gels still carries a black-box warning for secondary exposure, and that warning exists for a reason.

For men over 50, the practical goal isn’t to chase the highest total testosterone number on a lab portal. It’s to build a protocol that improves symptoms, keeps hematocrit and estradiol manageable, and is realistic enough that you will still be following it six months from now. That’s a conversation to have with your prescribing clinician, not a challenge coin from TRT Twitter.

Choosing Between Cream and Injections: A Decision Framework

Most men don’t need a philosophical position on TRT route. They need a clean sorting mechanism.

Cream may make more sense if you want steadier daily levels, you are sensitive to hormonal swings, you have had hematocrit issues on injections, or you strongly prefer avoiding needles. It can also fit men who are disciplined with routines and don’t mind a daily application window.

Injections may make more sense if you want the simplest dose certainty, lower monthly cost, and less concern about transfer risk. AlphaMD notes generic testosterone cypionate often lands around $30 to $50 per month, while branded gels can run $50 to $150 per month. That gap isn’t trivial if you’re paying out of pocket.

Monitoring differs too. Gel or cream users often test 2 to 4 hours after application, while injection users commonly test at trough, just before the next dose. Both routes still need follow-up labs at 3, 6, and 12 months, including total testosterone, free testosterone, estradiol, hematocrit, and PSA, as the American Urological Association guideline recommends.

The simplest framework looks like this:

If stability and lower erythrocytosis risk matter most, cream has a strong case.

If predictable delivery, lower cost, and fewer daily logistics matter most, injections have a strong case.

If you’re drawn to scrotal cream, understand the DHT tradeoff and the off-label nature of that protocol.

If you’re drawn to injections, pay attention to dose size and frequency, because bad injection design creates half the horror stories people blame on testosterone itself.

Neither route is automatically better. The best route is the one whose tradeoffs match your physiology, your schedule, and your tolerance for monitoring. Then it has to be reviewed against your own labs and history with a provider who actually watches the numbers.

Frequently Asked Questions

Can I switch from injections to cream or from cream to injections if symptom relief is poor?

Usually yes, provided the transition is managed with updated dosing and follow-up labs. Poor results on one route don’t automatically mean TRT is a bad fit. Sometimes the issue is timing, absorption, dose size, or injection frequency rather than the molecule itself.

Does scrotal cream create more hair-loss or prostate concern because of higher DHT?

It can raise that concern because scrotal application tends to increase DHT more than standard transdermal sites or many injection protocols. That doesn’t guarantee hair loss or prostate symptoms, but it makes monitoring and symptom review more important, especially if you already have androgen-sensitive issues.

What injection frequency usually gives the most stable levels without daily application?

For many men, weekly injections are steadier than every-two-weeks dosing, and twice-weekly split dosing is steadier still. The right schedule depends on symptom response, hematocrit, estradiol, and how aggressive the total weekly dose is.

How quickly does testosterone cream work compared with injections?

Scrotal compounded cream can reach therapeutic serum levels within about two hours, based on the Iyer Andrology study. Injections also raise levels quickly, but their profile usually includes a sharper early peak followed by a decline over the dosing interval.

Which route carries lower hematocrit risk for men over 50?

Topical therapy generally carries the lower hematocrit risk. In the Pastuszak study, erythrocytosis occurred far more often with injections than with gels. That makes route selection especially relevant for older men with cardiovascular risk factors or a prior history of elevated hematocrit.

The Bottom Line

For most men over 50, this isn’t a contest between a good option and a bad one. It’s a tradeoff between smoother day-to-day stability and more direct dose certainty. Cream usually wins on stability and hematocrit risk, injections usually win on simplicity and cost, and the right answer depends on how carefully the protocol is built and monitored with your provider.

Related: how TRT delivery method affects hematocrit and cardiovascular risk

Related: what the TRAVERSE trial and FDA label change say about TRT heart safety

Related: how to read your TRT lab results including total T, free T, and SHBG

This article is for informational purposes only and is not financial advice. Consult a qualified professional for personalized guidance.